Mathematics, like many other scientific endeavors, is increasingly using artificial intelligence. Of course, math is the backbone of AI, but mathematicians are also turning to these tools for tasks ...

I tend to divide my workday into blocks. Within minutes of waking up — we’re usually up by 5.30 a.m. — I sit down to write at least one Inc. article. Then I spend four to five hours writing a book, ...

Over the weekend, Neel Somani, who is a software engineer, former quant researcher, and a startup founder, was testing the math skills of OpenAI’s new model when he made an unexpected discovery. After ...

The original version of this story appeared in Quanta Magazine. In 1939, upon arriving late to his statistics course at UC Berkeley, George Dantzig—a first-year graduate student—copied two problems ...

When Apple released iOS 26 back in September, many iPhone users were eager to try its new customizations, features, and security updates. But, as with major software transitions, the launch hasn't ...

During an interview with The New York Times, Stewart was asked about method acting after the conversation turned to Marlon Brando’s work on “Superman: The Movie.” The legendary actor reportedly would ...

Cognitive struggles are climbing across the U.S., especially among young and economically disadvantaged adults. Rates of self-reported cognitive disability nearly doubled in people under 40 between ...

That’s how Meta’s chief AI scientist Yann LeCun described the blowback after OpenAI researchers did a victory lap over GPT-5’s supposed math breakthroughs. Google DeepMind CEO Demis Hassabis added, ...

The leading approach to the simplex method, a widely used technique for balancing complex logistical constraints, can’t get any better. In 1939, upon arriving late to his statistics course at the ...

A growing number of U.S. adults—particularly those under 40—are reporting serious challenges with memory, concentration and decision-making, according to a new study published in Neurology.

ROOTSTOWN, Ohio--(BUSINESS WIRE)--BioMendics, a clinical-stage biopharmaceutical company focused on rare skin diseases, today announced the launch of the TAMES-02 clinical trial—a multicenter, ...